Physician profile
William H Ballinger
NPI 1659341170
$7,806.92
in general payments reported to CMS, 2019-2025
17 companies · $1,006 in 2025
The $1,006 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $992 · 2020: $357 · 2021: $3,642 · 2022: $502 · 2023: $541 · 2024: $767 · 2025: $1,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,314.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $5,404.02 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Abbvie INC. | $520.93 | 2022-2025 | Ozurdex, Durysta |
| Sun Pharmaceutical Industries INC. | $284.08 | 2019-2025 | Cequa |
| Astellas Pharma US INC | $244.68 | 2023-2025 | Izervay |
| Bausch & Lomb Americas INC. | $208.25 | 2022-2024 | Infuse, Vyzulta, Xipere |
| Oyster Point Pharma, INC. | $202.98 | 2022-2025 | Tyrvaya |
| Maculogix, INC. | $197.09 | 2019 | |
| Alcon Vision LLC | $181.96 | 2020-2025 | Rocklatan |
| Tarsus Pharmaceuticals, INC. | $121.96 | 2024-2025 | Xdemvy |
| Amgen INC. | $100.92 | 2024-2025 | Tepezza |
| Shire North American Group INC | $97.72 | 2019 | |
| Allergan, INC. | $70.15 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $61.27 | 2019-2021 | |
| Harrow Eye, LLC | $46.40 | 2024-2025 | Vevye |
| Thea Pharma INC. | $26.69 | 2024 | Iyuzeh |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $20.77 | 2021 | |
| Horizon Therapeutics Plc | $17.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ballinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.